Quanterix Announces Landmark Nature Study Redefining Alzheimer’s Disease Neuropathology Prevalence
Go back to Quanterix Announces Landmark Nature Study Redefining Alzheimer’s Disease Neuropathology Prevalence| (NASDAQ: QTRX) | Delayed: 3.16 -0.03 (0.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.19 | 52 Week High | $ | |||
| Open | $3.17 | 52 Week Low | $ | |||
| Day High | $3.20 | P/E | N/A | |||
| Day Low | $3.03 | EPS | $ | |||
| Volume | 423,782 | |||||

